Jake Trotter, ESPN Staff WriterJul 21, 2023, 05:57 PM ET Close Jake Trotter covers the Cleveland Browns for ESPN. He joined ESPN in 2011 covering college football. Before that, he worked at The Oklahoman, Austin American-Statesman and Middletown (Ohio) Journal newspapers. You can follow him on Twitter @Jake_Trotter. BEREA, Ohio — Wide receiver Marquise Goodwin […]
The Browns placed veteran receiver Marquise Goodwin on the non-football illness list Friday, and now we know why. Blood clots in his lungs and legs will force Goodwin to miss the start of training camp, the team announced. Goodwin, who is entering his 10th season, began experiencing discomfort in his legs and complained of shortness […]
Companies Pfizer Inc Follow Syros Pharmaceuticals Inc Follow July 21 (Reuters) – Syros Pharmaceuticals (SYRS.O) said on Friday Pfizer (PFE.N) will terminate a license deal between the companies related to the development of novel therapies for two blood disorders. Shares of Syros were down 5.7% in trading after the bell. The termination will end the […]
Quavo has released an epic trailer to promote his upcoming new album, Rocket Power — and it includes a dig at his former Migos groupmate Offset. In the promotional clip, Huncho can be seen standing in a destitute area as he watches a space rocket prepare for launch — which is both a nod to […]
Wide receiver Marquise Goodwin was one of four players who were put on the non-football injury list to start training camp by the Cleveland Browns. And now it has come out that he has been placed on the list due to some issues with blood clots in both his lungs and his legs (according to […]
HARRISONBURG, Va. (WHSV) – The Virginia Department of Motor Vehicles will allow Virginia residents to put their blood type on I.D. cards like child identification cards and Driver’s Licenses. VA DMV will add a new line to applications for licenses as well as renewals. People in the commonwealth will have a new, optional symbol on […]
By Denny Jacob Gilead Sciences has discontinued its Phase 3 study of magrolimab in higher-risk myelodysplastic syndromes. The biopharmaceutical company said on Friday the study was discontinued due to futility based on a planned analysis. Gilead said it recommends discontinuing treatment with magrolimab in patients with myelodysplastic syndromes,…
Shares of Gilead Sciences Inc. GILD, +0.88% dropped nearly 2% in the extended session Friday after the pharma company said it has ended a late-stage trial of a treatment for a rare type of blood cancer after an analysis. “The health and well-being of patients are our top priorities and while this is disappointing news […]
July 21 (Reuters) – Gilead Sciences Inc (GILD.O) said on Friday it was stopping a late-stage trial of its blood cancer treatment following an analysis. Reporting by Sriparna Roy in Bengaluru Editing by Vinay Dwivedi Our Standards: The Thomson Reuters Trust Principles.
BLOOMINGTON — Bloomington-Normal first responders will go head-to-head in a series of “Battle of the Badges” blood drives next month to see who can bring in the most blood donors. The Bloomington Police Department’s drive will be 8 a.m. to 2 p.m. on Wednesday, Aug. 9 in the Osborn Room at the police station, 305 S. […]